Alamar Biosciences to Report Second Quarter 2026 Financial Results on August 10, 2026

Alamar Biosciences (Nasdaq: ALMR) announced it will report its second quarter 2026 financial results after market close on Monday, August 10, 2026.

Rhea-AI Summary

Alamar Biosciences (Nasdaq: ALMR) announced it will report its second quarter 2026 financial results after market close on Monday, August 10, 2026. Management will host a webcast conference call at 1:30 p.m. PT / 4:30 p.m. ET, accessible via the Investors section of the company website, with an archived replay available.

Argus Jul 15 session

-3.40% close to close Open Argus

Details

Market reaction after 2Q26 earnings report date: ALMR -3.40% in the Jul 15 session

In the Jul 15 session, ALMR declined 3.40%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This 2Q26 earnings date sits against Q1’s rapid growth—revenue of $26.0 million, up 99%—and recent n...

Analysis

This 2Q26 earnings date sits against Q1’s rapid growth—revenue of $26.0 million, up 99%—and recent net insider buying of 1,411,764 shares. With reported low short positioning, investors may focus on whether Q2 sustains that growth trajectory and loss profile.

Key Figures

Earnings release date: August 10, 2026 Conference call time (PT): 1:30 p.m. Conference call time (ET): 4:30 p.m.

Earnings release date

August 10, 2026

Second quarter 2026 financial results to be reported after market close

Conference call time (PT)

1:30 p.m.

Start time of Q2 2026 results webcast in Pacific Time

Conference call time (ET)

4:30 p.m.

Start time of Q2 2026 results webcast in Eastern Time

Historical Context

5 past events · Latest: Jul 13

5 events

1. Jul 13

   Partnership announcement

   24h Move

   -3.6%

   National proteomics initiative profiling 21,000 plasma samples from 10,000 participants.

2. Jul 10

   Conference data highlight

   24h Move

   +7.3%

   NULISA platform featured in over 140 AAIC 2026 presentations.

3. Jul 07

   Product launch

   24h Move

   -1.7%

   Launch of first multiplexed blood-based immunoassay for eMTBR-Tau.

4. May 08

   Earnings report

   24h Move

   +1.3%

   Q1 2026 revenue rose to $26.0M with 99% year-over-year growth.

5. May 05

   Conference participation

   24h Move

   -0.3%

   Planned presentation at BofA Securities 2026 Healthcare Conference.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

FREMONT, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today announced it will report financial results for the second quarter 2026 after market close on Monday, August 10, 2026. Company management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the “Investors” section of the company website at: www.alamarbio.com. The webcast will be archived and available for replay after the event.

About Alamar Biosciences

Alamar is a commercial-stage proteomics company establishing a gold standard in protein detection and analysis. Leveraging our proprietary NULISA™ technology and the ARGO™ HT System, our platform is designed to detect protein biomarkers at extremely low concentrations in blood with ultra-high sensitivity, high specificity, flexible multiplexing, broad dynamic range and seamless automation. We refer to this combination of features as “Precision Proteomics,” and believe it fills a critical gap in the field of advanced proteomics, helping researchers unlock the full spectrum of protein biomarkers across disease states. Learn more at alamarbio.com.

Investor contact:

investors@alamarbio.com

Media contact:

media@alamarbio.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Alamar Biosciences (ALMR) report Q2 2026 earnings?

Alamar Biosciences will report its Q2 2026 financial results on Monday, August 10, 2026, after market close. According to Alamar Biosciences, the release will be followed by a webcast conference call the same afternoon.

What time is the Alamar Biosciences (ALMR) Q2 2026 earnings call on August 10, 2026?

The Alamar Biosciences Q2 2026 earnings call starts at 1:30 p.m. Pacific / 4:30 p.m. Eastern on August 10, 2026. According to Alamar Biosciences, company management will host the webcast immediately after the financial results are released.

How can investors listen to the Alamar Biosciences (ALMR) Q2 2026 earnings webcast?

Investors can access the Q2 2026 earnings webcast through the “Investors” section of www.alamarbio.com. According to Alamar Biosciences, live audio will be streamed online and does not mention a separate dial-in number.

Will a replay of the Alamar Biosciences (ALMR) Q2 2026 earnings call be available?

Yes, a replay of the Q2 2026 earnings webcast will be available after the event. According to Alamar Biosciences, the webcast will be archived on the company’s website for investors to access later.

What is the purpose of the Alamar Biosciences (ALMR) August 10, 2026 webcast?

The August 10, 2026 webcast will discuss second quarter 2026 financial results after market close. According to Alamar Biosciences, company management will host the conference call to review and comment on the reported results.